Human-Relevant Drug Response Profiling
We enable a future where therapies are evaluated in human-relevant models before reaching clinical trials, accelerating discovery while protecting patients.
A Human-Centered 3R
Reduce
Patient exposure to ineffective treatments.
Refine
Clinical trial design through better patient selection.
Replace
Non-predictive models with human-relevant systems.
- Almi-supported startup
- 10+ years translational research
- Based in Sweden
Human-Relevant Models for Better Translational Research
Traditional preclinical models remain essential research tools, yet they often fall short in fully capturing the biological complexity of human tumors. Organoid-based tumor models provide a complementary human-relevant platform that preserves key features of tumor biology, enabling quantitative functional evaluation for translational oncology research.
Human-Relevant Biology
Organoid-based tumor models preserve key structural and biological characteristics of human tumors, providing physiologically relevant systems for functional studies.
Functional Evidence
Generate quantitative ex vivo drug response data that complement molecular profiling and support translational oncology research.
Regulatory Alignment
Human-relevant New Approach Methodologies (NAMs), including organoid-based models, are increasingly recognized by regulatory agencies as complementary tools for modern preclinical research.
Sustainable Science
Human-relevant experimental models help reduce reliance on animal studies while supporting more ethical, reproducible and predictive research.
Supporting Translational Oncology at Every Stage
From early drug discovery to patient-specific functional studies, our research services generate standardized, human-relevant functional data tailored to your scientific objectives.
Need a custom workflow? Talk to us about customised solutions →
One Platform. Multiple Research Pathways.
Whether you're advancing a therapeutic candidate, investigating biomarkers, conducting translational clinical studies, or exploring patient-specific functional responses, the 3DxCell Platform provides standardized, human-relevant functional evidence tailored to your scientific objectives.
1Pharmaceutical Companies
Generate human-relevant functional evidence to support preclinical candidate evaluation, translational research, and clinical development strategies.
2Biotechnology Companies & CROs
Accelerate research pipelines using standardized organoid-based tumor models and quantitative functional assays designed for evidence-driven drug development.
3Hospitals & Clinical Research
Support translational clinical studies through patient-specific functional drug response profiling and biomarker-informed cohort stratification.
4Academic Research Groups
Advance mechanistic studies, biomarker discovery, and translational oncology research using standardized human-relevant experimental models.
Ready to Test Your Compound on Human Tumor Models?
Tell us about your project. We'll come back with a tailored proposal.